vimarsana.com

Page 39 - மருந்து ஒழுங்குமுறை அதிகாரம் ஆஃப் பாக்கிஸ்தான் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pakistan approves third Chinese COVID-19 jab despite low efficacy rate

Pakistan approves third Chinese COVID-19 jab despite low efficacy rate Citing officials, Geo News reported that the Drug Regulatory Authority of Pakistan (DRAP) has granted Emergency Use Authorization (EUA) to another Chinese vaccine, CoronaVac PTI | April 9, 2021 | Updated 15:16 IST Pakistan approved the emergency use of the third Chinese vaccine, despite its low efficacy rate, on Thursday. Citing officials, Geo News reported that the Drug Regulatory Authority of Pakistan (DRAP) has granted Emergency Use Authorization (EUA) to another Chinese vaccine, CoronaVac. Earlier, Pakistan had granted the EUA to China s two-dose Sinopharm and single-dose Convidecia vaccine developed by the Cansino Biologicals Inc. This would be the fifth coronavirus vaccine and the third Chinese vaccine to be used in Pakistan. UK s AstraZeneca and Russian Sputnik V vaccines have also been approved by the DRAP.

Coronavirus: Pakistan okays emergency use of third Chinese vaccine

Coronavirus: Pakistan okays emergency use of third Chinese vaccine By Friday Apr 09, 2021 A health worker receives a dose of Sinopharm s COVID-19  vaccine at a vaccination centre in Karachi, February 8, 2021. Reuters/File DRAP has approved the emergency use of another Chinese vaccine, CoronaVac. This would be the fifth coronavirus vaccine and the third Chinese vaccine to be used in Pakistan. UK s AstraZeneca and Russian Sputnik V vaccines have also been given Emergency Use Authorisation in Pakistan.  KARACHI: Amid the intensifying third COVID-19 wave, the Drug Regulatory Authority of Pakistan (DRAP) has granted Emergency Use Authorization (EUA) to another Chinese vaccine, CoronaVac, officials told The News on Thursday.

Pakistan approves emergency use of third Chinese COVID vaccine, despite its low efficacy rate

Pakistan approves emergency use of third Chinese COVID vaccine, despite its low efficacy rate ANI | Updated: Apr 09, 2021 13:21 IST Karachi [Pakistan], April 9 (ANI): Pakistan approved the emergency use of the third Chinese vaccine, despite its low efficacy rate, on Thursday. Citing officials, Geo News reported that the Drug Regulatory Authority of Pakistan (DRAP) has granted Emergency Use Authorization (EUA) to another Chinese vaccine, CoronaVac. Earlier, Pakistan had granted the EUA to China s two-dose Sinopharm and single-dose Convidecia vaccine developed by the Cansino Biologicals Inc. This would be the fifth coronavirus vaccine and the third Chinese vaccine to be used in Pakistan. UK s AstraZeneca and Russian Sputnik V vaccines have also been approved by the DRAP.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.